XML 68 R2.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash $ 23,696 $ 606,267
Prepaid consulting expense 2,228 18,935
Deposits and other prepaids 749 15,791
Total current assets 26,673 640,993
Property, plant and equipment, net 249,987 248,922
Right of use asset, net 11,740 30,290
Total Assets 288,400 920,205
Current liabilities    
Accounts payable and accrued expenses 636,074 565,009
Deferred revenue 140,000 140,000
Convertible notes payable, net of discount of $10,525 and $0, respectively 139,476
Convertible notes payable, related parties 15,000
Convertible notes payable, in default 235,300 355,300
Convertible notes payable, in default - related parties 689,500 789,500
Notes payable, net of discount of $67,708 and $0, respectively 1,000,000 404,786
Notes payable, in default 112,000 112,000
Notes payable, in default - related parties 18,500 18,500
Shareholder loan 5,000 5,000
Operating lease liability, current 11,976 18,483
Finance lease liability, current 26,304 22,263
Total current liabilities 3,029,130 2,430,841
Operating lease liability, long-term 11,974
Finance lease liability, long-term 71,465 99,917
Total Liabilities 3,100,595 2,542,732
Stockholders' Deficit    
Common stock, $0.0001 par value - 9,900,000,000 shares authorized; 8,944,932,833 and 8,314,141,446 shares issued and outstanding at December 31, 2024 and 2023 894,494 831,415
Common stock to be issued, $0.0001 par value, 33,039,877 and 31,039,877 shares outstanding at December 31, 2024 and 2023, respectively 3,304 3,104
Additional paid in capital 28,534,184 25,890,412
Accumulated deficit (32,244,177) (28,347,458)
Total Stockholders' Deficit (2,812,195) (1,622,527)
Total Liabilities and Stockholders' Deficit 288,400 920,205
Series A Preferred Stock [Member]    
Stockholders' Deficit    
Series B - 60 shares issued and outstanding at December 31, 2024 and 2023, 60 Series B preferred shares authorized.
Series B Preferred Stock [Member]    
Stockholders' Deficit    
Series B - 60 shares issued and outstanding at December 31, 2024 and 2023, 60 Series B preferred shares authorized.